A Study of Ruxolitinib in Patients With Graft-Versus Host Disease

Clinical trial NCT07594587 · RECRUITING

Trial details

NCT number: NCT07594587
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Graft-Versus-Host Disease

Start date: 2026-05-11
Primary completion: 2030-05-15
Enrollment: 395

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.